CTOs on the Move

Scripps Translational Science Institute

www.stsiweb.org

 
The Scripps Translational Science Institute (STSI) at The Scripps Research Institute (TSRI) aims to replace the status-quo of one-size-fits-all-medicine with individualized health care that is based on the known genetic factors influencing health and disease and that takes advantage of advances in digital technology for real-time health monitoring.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.stsiweb.org
  • 3344 North Torrey Pines Court Suite 300
    La Jolla, CA USA 92037
  • Phone: 858.784.2028

Executives

Name Title Contact Details

Funding

Scripps Translational Science Institute raised $34M on 05/02/2018

Similar Companies

BenevolentAI

BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange.

Emalex Biosciences

Developing new treatments for rare and orphan neurological conditions.

Cerapedics

i-FACTOR Peptide Enhanced Bone Graft is a drug/device combination that creates a new category of bone graft technology. Take a moment to review our introduction to i-FACTOR, our Level-1 IDE study and comparative performance sections given below.

Advanced Enzyme Technologies

Advanced Enzyme Technologies Limited is engaged in business of manufacturing and sale of enzymes. The Companys geographical segments include Within India and Outside India. It provides solutions to industries, such as human healthcare and nutrition, a...

Ventria BioScience

Ventria BioScience is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.